Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
WAY-100635: A Precise 5-HT1A Assay Control
2026-08-12
WAY-100635 provides a rigorous pharmacological control for separating 5-HT1A receptor signaling from broader serotonin and endocannabinoid effects. This article translates recent pain findings into practical assay and interpretation strategies.
-
Camptothecin: Topoisomerase I Inhibitor Guide
2026-08-11
Camptothecin is a topoisomerase I inhibitor and DNA damage inducer used in cancer biology research. It stabilizes topoisomerase I–DNA cleavage complexes and engages γH2AX, ATM-Chk2-p53-p21, and AMPK-TSC2-mTOR signaling in reported experimental models.
-
GSK3 Inhibition and Mycobacterium tuberculosis Control
2026-08-11
A 2024 iScience study identifies glycogen synthase kinase 3 as a host pathway that supports intracellular Mycobacterium tuberculosis growth in macrophages. By combining chemical screening, genetic perturbation, and phosphoproteomic analysis, the work supports GSK3 inhibition as a host-directed strategy while highlighting the need for in vivo validation and careful toxicity assessment.
-
NPC2, Cholesterol, and Ferroptosis in Glioblastoma
2026-08-10
The 2026 Cell Biology International study links NPC2-dependent cholesterol handling with GPX4-associated ferroptosis and malignant behavior in glioblastoma. Its combination of clinical tissue analysis, public-cohort interpretation, and NPC2 perturbation in LN18 cells provides a useful framework for evaluating cholesterol metabolism as a mechanistic and prognostic dimension of GBM biology.
-
PRINT: RNA-Mediated Safe-Harbor Insertion
2026-08-09
The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to insert transgenes directly into a multicopy human safe-harbor locus through target-primed reverse transcription. In cultured human primary cells, the method supported efficient acquisition of multikilobase transgenes while avoiding donor DNA, highlighting a potentially lower-mutagenesis route for stable genome engineering.
-
THZ1 Workflow for Covalent CDK7 Inhibition
2026-08-08
THZ1 links covalent CDK7 inhibition to practical studies of RNA polymerase II phosphorylation, transcriptional dependency, and T-ALL cell proliferation. This guide combines product-specific handling with an assay framework inspired by super-enhancer-driven KLF6 regulation in adipogenesis.
-
NLRP3 Astrocyte Remodeling in Morphine Tolerance
2026-08-07
Yuan et al. link spinal NLRP3 inflammasome activation with a shift toward an A1-like reactive astrocyte phenotype during morphine tolerance. Their pharmacological intervention shows that MCC950 slows tolerance development and reverses associated changes in NLRP3, IL-18, GFAP, C3, and S100A10, while also defining important limits for interpreting this mechanism.
-
Fosinopril Sodium in Translational Cardiovascular Modeling
2026-08-07
Explore how Fosinopril sodium, a potent ACE inhibitor, enables advanced hypertension research and cardiovascular disease modeling. This article offers unique, practical assay guidance and unpacks mechanistic insights that go beyond prior reviews.
-
N1-Methylpseudouridine: Elevating mRNA Translation in CRISPR
2026-08-06
N1-Methylpseudouridine sets a new standard for mRNA modification, delivering superior protein expression and minimized immune activation. This guide translates the latest research into actionable protocols and troubleshooting steps for CRISPR-based transcriptome analysis and beyond.
-
BIIE 0246: Strategic Y2R Antagonism in Neuro-Cardiac Researc
2026-08-06
Discover how BIIE 0246, a selective neuropeptide Y Y2 receptor antagonist, empowers translational researchers to probe the mechanistic underpinnings of metabolic, behavioral, and cardiac regulation. This article integrates recent insights on the adipose-neural axis in arrhythmias, provides protocol parameters, benchmarks BIIE 0246 against the evolving competitive landscape, and charts new frontiers for neuropeptide Y research.
-
TRPV1 and TRPA1 Activation Drives TSLP Release in Nasal Epit
2026-08-05
The reference study reveals that TRPV1 and TRPA1 channels in nasal epithelial cells regulate TSLP and inflammatory cytokine release via a Ca2+/NFAT signaling axis. These findings clarify the sensory ion channel mechanisms underlying airway inflammation and provide a foundation for targeted research in neurophysiology and airway disease.
-
Simvastatin (Zocor) in Cancer and Lipid Research Workflows
2026-08-05
Simvastatin (Zocor) bridges cholesterol and oncology research, enabling robust, reproducible workflows for apoptosis induction and lipid metabolism modulation. APExBIO’s high-purity Simvastatin streamlines experimental design and troubleshooting, empowering advanced studies in hyperlipidemia and hepatic cancer models.
-
Sodium Oxamate in Cancer Metabolism: Applied Workflows & Ins
2026-08-04
Sodium Oxamate (Oxamic Acid) is redefining cancer metabolism research by enabling precise, reproducible inhibition of LDH-A and glycolytic flux. This guide distills cross-validated protocols, troubleshooting wisdom, and impactful findings—such as its role in modulating lactylation-driven DNA repair in triple-negative breast cancer—into an actionable resource for metabolic and translational researchers.
-
BicD and MAP7 Synergistically Activate Drosophila Kinesin-1
2026-08-04
This study demonstrates how the adaptor protein BicD and microtubule-associated protein MAP7 independently and cooperatively activate Drosophila kinesin-1 via distinct mechanisms. These findings clarify the regulatory interplay that enables robust bidirectional cargo transport in cells, informing future biochemical and motor protein research.
-
Cyanine 5-dCTP: Fluorescent DNA Labeling for Advanced EOS
2026-08-03
Cyanine 5-dCTP empowers high-efficiency DNA labeling in enzymatic oligonucleotide synthesis, enabling sensitive nucleic acid detection and robust probe design. Its integration with ordered DNA nanostructures sets a new benchmark for assay fidelity and workflow flexibility.